Introducing Precision Addiction Management of Reward Deficiency Syndrome, the Construct That Underpins All Addictive Behaviors

Introducing Precision Addiction Management of Reward Deficiency Syndrome, the Construct That Underpins All Addictive Behaviors

Bibliographic Details
Main Authors:	Kenneth Blum, Marjorie C. Gondré-Lewis, David Baron, Panayotis K. Thanos, Eric R. Braverman, Jennifer Neary, Igor Elman, Rajendra D. Badgaiyan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-11-01
Series:	Frontiers in Psychiatry
Subjects:	reward deficiency syndrome (RDS) dopamine homeostasis genetic addiction risk score (GARS) comprehensive analysis of reported drugs (CARD) precision addiction management (PAM)
Online Access:	https://www.frontiersin.org/article/10.3389/fpsyt.2018.00548/full

Similar Items

Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case–Control Subjects
by: Kenneth Blum, et al.
Published: (2022-08-01)

Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia’s Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family
by: Catherine A. Dennen, et al.
Published: (2022-11-01)

A Novel Precision Approach to Overcome the “Addiction Pandemic” by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration
by: Kenneth Blum, et al.
Published: (2021-03-01)

Researching Mitigation of Alcohol Binge Drinking in Polydrug Abuse: KCNK13 and RASGRF2 Gene(s) Risk Polymorphisms Coupled with Genetic Addiction Risk Severity (GARS) Guiding Precision Pro-Dopamine Regulation
by: Kenneth Blum, et al.
Published: (2022-06-01)

Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids
by: Mauro Ceccanti, et al.
Published: (2022-12-01)

Positive Clinical Outcomes for Severe Reported Pain Using Robust Non-Addictive Home Electrotherapy—A Case-Series
by: Anish Bajaj, et al.
Published: (2023-02-01)

Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?
by: Kenneth Blum, et al.
Published: (2022-10-01)

Genetic Addiction Risk and Psychological Profiling Analyses for “Preaddiction” Severity Index
by: Kenneth Blum, et al.
Published: (2022-10-01)

DNA Directed Pro-Dopamine Regulation Coupling Subluxation Repair, H-Wave<sup>®</sup> and Other Neurobiologically Based Modalities to Address Complexities of Chronic Pain in a Female Diagnosed with Reward Deficiency Syndrome (RDS): Emergence of Induction of “Dopamine Homeostasis” in the Face of the Opioid Crisis
by: Anish Bajaj, et al.
Published: (2022-08-01)

Dopamine and glucose, obesity and Reward Deficiency Syndrome
by: Kenneth eBlum, et al.
Published: (2014-09-01)

Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing
by: Edward Justin Modestino, et al.
Published: (2022-11-01)

Exercise Modulates Brain Glucose Utilization Response to Acute Cocaine
by: Colin Hanna, et al.
Published: (2022-11-01)

Futuristic Exploration of Addiction Neuroscience in the Genomic Era
by: Blum K, et al.
Published: (2023-12-01)

Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans: Embracing Putative Induction of Dopamine Homeostasis
by: Kenneth Blum, et al.
Published: (2021-03-01)

Neurogenetic and Epigenetic Aspects of Cannabinoids
by: Catherine A. Dennen, et al.
Published: (2022-08-01)

Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It “Blowin’ in the Wind”?
by: Kenneth Blum, et al.
Published: (2022-02-01)

Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?
by: Marjorie C. Gondré-Lewis, et al.
Published: (2022-04-01)

“TO BE OR NOT TO BE” GWAS Ends the Controversy about the DRD2 Gene as a Determinant of Reward Deficiency Syndrome (RDS)
by: Blum K, et al.
Published: (2023-10-01)

The Role of Estrogen Signaling and Exercise in Drug Abuse: A Review
by: Rania Ahmed, et al.
Published: (2024-01-01)

Brain Mapping the Effects of Chronic Aerobic Exercise in the Rat Brain Using FDG PET
by: Colin Hanna, et al.
Published: (2022-05-01)

The First Exploratory Personalized Medicine Approach to Improve Bariatric Surgery Outcomes Utilizing Psychosocial and Genetic Risk Assessments: Encouraging Clinical Research
by: Panayotis K. Thanos, et al.
Published: (2023-07-01)

High intensity interval training exercise increases dopamine D2 levels and modulates brain dopamine signaling
by: John Tyler, et al.
Published: (2023-12-01)

Exercise Modifies the Brain Metabolic Response to Chronic Cocaine Exposure Inhibiting the Stria Terminalis
by: Colin Hanna, et al.
Published: (2023-12-01)

Genetic Correlates as a Predictor of Bariatric Surgery Outcomes after 1 Year
by: Panayotis K. Thanos, et al.
Published: (2023-09-01)

A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing “Precision Behavioral Management”
by: Blum K, et al.
Published: (2021-12-01)

Opioid use disorder: current trends and potential treatments
by: Yu Kyung Lee, et al.
Published: (2024-01-01)

Behavioral, Neurochemical and Developmental Effects of Chronic Oral Methylphenidate: A Review
by: Daniela Senior, et al.
Published: (2023-03-01)

Chronic Methylphenidate Effects on Brain Gene Expression: An Exploratory Review
by: Klein SR, et al.
Published: (2024-02-01)

Preliminary Observations of Personalized Repetitive Magnetic Stimulation (PrTMS) Guided by EEG Spectra for Concussion
by: Milan T. Makale, et al.
Published: (2023-08-01)

Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z.
by: Marcelo Febo, et al.
Published: (2017-01-01)

Editorial: Women in behavioral neuroscience: 2022
by: Lisa Y. Maeng, et al.
Published: (2024-02-01)

FOXN3 and GDNF Polymorphisms as Common Genetic Factors of Substance Use and Addictive Behaviors
by: Andrea Vereczkei, et al.
Published: (2022-04-01)

Neurogenetics and Epigenetics of Loneliness
by: Bowirrat A, et al.
Published: (2023-11-01)

Fatty Acid-Binding Protein 5 Gene Deletion Enhances Nicotine-Conditioned Place Preference: Illuminating the Putative Gateway Mechanisms
by: Nicole Roeder, et al.
Published: (2023-01-01)

Awareness integration theory A Psychological and genetic path to self-directed Neuroplasticity
by: Foojan Zeine, et al.
Published: (2024-06-01)

Examination of the Addictive and Behavioral Properties of Fatty Acid Binding Protein Inhibitor SBFI26
by: Panayotis eThanos, et al.
Published: (2016-04-01)

A Theoretical Computer Science Perspective on Consciousness and Artificial General Intelligence
by: Lenore Blum, et al.
Published: (2023-06-01)

Evoked Potentials and Memory/Cognition Tests Validate Brain Atrophy as Measured by 3T MRI (NeuroQuant) in Cognitively Impaired Patients.
by: Eric R Braverman, et al.
Published: (2015-01-01)

A Case Series: Successfully Preventing COVID-19 Outbreak in a Residential Community Setting at a Drug and Alcohol Addiction Treatment Center
by: Kenneth Hanton, et al.
Published: (2021-01-01)

Epitaxy and Step Structures on Semiconductor Surfaces
by: Mochrie, Simon G. J., et al.
Published: (2010)